• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT MEDICAL EPIC¿ SUPRA VALVE (AORTIC); HEART-VALVE, NON-ALLOGRAFT TISSUE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT MEDICAL EPIC¿ SUPRA VALVE (AORTIC); HEART-VALVE, NON-ALLOGRAFT TISSUE Back to Search Results
Catalog Number ESP200-23
Medical Device Problem Codes Incomplete Coaptation (2507); Intravalvular regurgitation (4068)
Health Effect - Clinical Code Mitral Valve Insufficiency/ Regurgitation (4451)
Date of Event 07/25/2024
Type of Reportable Event Serious Injury
Event or Problem Description
It was reported that on (b)(6) 2024, a 23mm epic plus supra valve was chosen for a procedure.The valve seemed to be coapting when saline tested and the valve was implanted with no noticeable issue.The leaflet function was tested with a bulb syringe with red rubber.When the pump off, upon echocardiogram (echo) review, it was noted that the valve developed an eccentric central jet that was moderate to severe.The physician went back in and noticed the valve did not seem to be coapting and decided to replace the valve.A new 23mm epic plus supra valve and completed the procedure.The patient remained hemodynamically stable throughout the procedure.There was some delay in the procedure but it was not clinically significant and the procedure finished without further incident.The patient was reported stable and recovering.
 
Additional Manufacturer Narrative
Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.
 
Additional Manufacturer Narrative
An event of a valve did not coapting well and explant was reported.A more comprehensive assessment, including histopathological examination of the valve tissue could not be performed as the device was not returned for analysis.It was indicated that the valve seemed to be coapting when saline tested and the valve was implanted with no noticeable issue.Images received appeared to show leaflets of the valve in open state inside the patient.The device history record was also reviewed to ensure that each manufacturing and inspection operation was performed, and the product met all specifications.Based on the limited information associated with this complaint, the exact cause of reported event cannot be conclusively determined.There is no indication of a product quality issue with respect to labeling design or manufacturing of the device.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EPIC¿ SUPRA VALVE (AORTIC)
Common Device Name
HEART-VALVE, NON-ALLOGRAFT TISSUE
Manufacturer (Section D)
ABBOTT MEDICAL
5050 nathan lane n
plymouth MN 55442
Manufacturer (Section G)
ST. JUDE MEDICAL LTDA. REG#3001883144
1301rua profvieira demendonça
bairro engenho nogueira 31.31 0-26
BR   31.310-260
Manufacturer Contact
karen krouse
5050 nathan lane n
plymouth, MN 55442
6517565400
MDR Report Key20010390
Report Number2135147-2024-04052
Device Sequence Number7257788
Product Code LWR
UDI-Device Identifier05415067033130
UDI-Public(01)05415067033130(17)260302(10)10344580
Combination Product (Y/N)N
Initial Reporter StateCA
Initial Reporter CountryUS
PMA/510(K) Number
P040021
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2024
Device Explanted Year2024
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 09/06/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date03/02/2026
Device Catalogue NumberESP200-23
Device Lot Number10344580
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Follow-Up
Initial Date Received by Manufacturer 07/25/2024
Supplement Date Received by Manufacturer08/21/2024
Initial Report FDA Received Date08/21/2024
Supplement Report FDA Received Date09/06/2024
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured03/03/2022
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient SexUnknown
-
-